Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

848
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
848
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

779
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
779
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

609
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
609
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

933
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
933
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

996
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
996
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

535
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
535

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Near and Far.

Journal of hospital medicine·2017
Same author

Outcomes After Implementation of an Alcohol Withdrawal Protocol at a Single Institution.

Hospital pharmacy·2016
Same journal

A Case Report of Unanticipated Difficult Intubation Due to Posterior Tracheal Angulation.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

Factors Influencing Outcomes of a Telehealth-Based Physical Activity Program in Older Veterans Postdischarge.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

Updates in Multiple Sclerosis Imaging.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

Impact of Retroactive Application of Updated Surveillance Guidelines on Endoscopy Center Capacity at a Large VA Health Care System.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

The Integration of Extended Reality in Arthroplasty: Reviewing Technological Progress and Clinical Benefits.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same journal

American Hunger Games: Food Insecurity Among the Military and Veterans.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
See all related articles

Related Experiment Video

Updated: Jan 29, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.9K

Cannabinoid Hyperemesis Syndrome.

J Eric Fleming1, Sean Lockwood1

  • 1is chief of the Hospitalist Section at Lexington VAMC in Kentucky. is a PGY-3 resident in the internal medicine department University of Kentucky, Primary Care Track and in the Hospital Medicine Track, and Dr. Lockwood is an assistant professor of medicine at the University of Kentucky College of Medicine, both in Lexington.

Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|February 16, 2019
PubMed
Summary
This summary is machine-generated.

Legislative changes and rising cases highlight the importance of recognizing tetrahydrocannabinol (THC) toxicity. This condition, though challenging to diagnose, requires clinical consideration due to its increasing prevalence.

More Related Videos

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

14.5K
Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.5K

Related Experiment Videos

Last Updated: Jan 29, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
05:25

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies

Published on: December 29, 2021

2.9K
Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:31

Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome

Published on: July 31, 2016

14.5K
Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
09:39

Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome

Published on: December 4, 2021

3.5K

Area of Science:

  • Toxicology
  • Public Health
  • Pharmacology

Background:

  • Increasing prevalence of conditions related to tetrahydrocannabinol (THC) use.
  • Legislative changes impacting access and use of THC-containing products.
  • Tetrahydrocannabinol toxicity presents diagnostic challenges in clinical settings.

Purpose of the Study:

  • To underscore the clinical importance of considering tetrahydrocannabinol toxicity.
  • To highlight the factors contributing to the rising significance of this condition.

Main Methods:

  • Review of current literature on THC toxicity.
  • Analysis of trends in legislative changes and prevalence data.
  • Discussion of diagnostic challenges and clinical implications.

Main Results:

  • Convergence of legislative shifts and increased THC prevalence elevates the importance of toxicity recognition.
  • Tetrahydrocannabinol toxicity is a difficult-to-diagnose condition demanding clinical attention.

Conclusions:

  • Clinicians must be aware of tetrahydrocannabinol toxicity due to its growing public health relevance.
  • The interplay of legal factors and rising usage necessitates a higher index of suspicion for THC-related adverse events.